Tweet
Economic Times
<img alt="" height="1" width="1" />
GlaxoSmithKline hit by lung cancer vaccine disappointment
The Guardian
The company has stopped a high profile clinical trial using the Mage-A3 vaccine to treat lung cancer, after deciding it would not be possible to find a subgroup of patients who might benefit. The news follows an admission that the treatment did not help patients ...
Glaxo Stops MAGE-A3 Cancer-Drug Trial in Another SetbackWall Street Journal
UPDATE 1-GlaxoSmithKline throws in towel on lung cancer vaccine trialReuters
GSK terminates lung cancer vaccine trialPMLiVE
MarketWatch -RTT News -IFA Magazine
all 27 news articles »
More...